target sites to liposomes could be imposed by some of the characteristics of the latter, namely size, charge and lipid composition. In this work, we have attempted to establish conditions for the transport of liposome-associated agents into areas of the body that liposomes can either reach only moderately or fail to enter altogether when given by certain routes. As model target areas we have chosen (a) malignant tissues approached by the intravenous route, (b) liver and spleen approached by the intraperitoneal route and (c) circulating blood approached by the intragastric route. A tracer (2.5mCi) of "'Inlabelled bleomycin (The Radiochemical Centre, Amersham, Bucks., U.K.), 200mg of glucose oxidase (Boehringer, Mannheim, W. Germany), 160i.u. of insulin B.P. (Weddel Pharmaceuticals, London E.C.1, U.K.) and a tracer (1OpCi) of '251-labelled polyvinylpyrrolidone (The Radiochemical Centre) were entrapped (Gregoriadis & Neerunjun, 1974 in liposomes composed of egg phosphatidylcholine and cholesterol (neutral, molar ratio 7:2) or the same supplemented with phosphatidic acid (negative) or stearylamine (positive, molar ratio 7:2: 1). Sonication, when appropriate, was carried out for up to 1 h. More than 60 %of the bleomycin was entrapped (negative liposomes) and up to 5 % of polyvinylpyrrolidone, 20 % of insulin and 50 % of glucose oxidase. In some experiments entrapment of insulin (more than 90% of the 160i.u. used) was carried out (Bayer, 1974) in liposomes composed of 6mg of phosphatidylinositol (sodium salt; Lipid Products, Epsom, Surrey, U.K.). More than 50% of 200mg of glucose oxidase and 2 % of a tracer (10,uCi) of 1251-labelled polyvinylpyrrolidone were entrapped in phosphatidylinositol liposomes composed of 20 and lOmg of lipid respectively. Association of insulin and glucose oxidase with such liposomes led to the formation of a precipitate, which did not clear on sonication (2min), and entrapped material was separated by centrifugation at l OOOOOg for 30min. Similarly sonicated free insulin and glucose oxidase retained their activity and served as controls.
'' 'In-labelled bleomycin, free or entrapped in liposomes, was injected into the tail vein of mice with implanted tumours as in Table 1 . The animals were killed 2 4 4 8 h later, so as to ensure complete removal of radioactivity from the blood. Uptake of radioactivity (Gregoriadis & Neerunjun, 1975) by the liver and tumour tissue was highest when the entrapped drug was used ( Table 1) . Uptake of the entrapped drug by tumours was greatest for very small liposomes (20min sonication), but hepatic uptake with suchliposomes was lower, probably as a result of the lower rate of elimination of small liposomes from the circulation (Juliano & Stamp, 1975) , which allows them longer contact with, and uptake by, other areas in the body (i.e. tumour tissue).
P
With liposome-entrapped 1251-labelled polyvinylpyrrolidone injected intraperitoneally into adult Sprague-Dawley rats, a considerable amount of radioactivity could be recovered in the liver and spleen at 24h (up to 32 and 5 % respectively of the injected dose). Only 6.9 and 1 .O % of free 1251-labelled polyvinylpyrrolidone, given by the same route, could be measured respectively in these two tissues.
After intragastric administration of free 1251-labelled polyvinylpyrrolidone, practically all radioactivity (more than 98 %) was recovered in the faeces and liver amounts were very low (0.07+0.02 % of the dose per organ) at all time-intervals. With 1251-labelled polyvinylpyrrolidone entrapped in neutral, negative and positive unsonicated or sonicated liposomes (including phosphatidylinositol liposomes), there was a small but statistically significant increase in hepatic uptake (0.17+0.02 %). Tests for liposome association of the radioactivity in the 24h faeces and in material sampled from the contents of the stomach and the intestines at time-intervals suggested that liposomal preparations of the composition used, regardless of size and charge, were largely disrupted after their emergence from the stomach, probably by the action of bile salts and/or phospholipases. However, oral pretreatment of rats with cholestearylamine (2.5g/kg body weight), which neutralizes bile salts, did not improve hepatic uptake. Glucose oxidase, which, when given intravenously into rats (5mg/kg body weight), was found to decrease blood glucose concentrations by more than 90% in 15min, was also given intragastrically (175mg/kg body weight), free or entrapped in negative and positive egg phosphatidylcholine liposomes. Blood glucose concentrations before and after such treatment, however, were virtually unchanged for 24h, and negative results were obtained with insulin administered in similar liposomes. However, when insulin associated with phosphatidylinositol liposomes was given, blood glucose concentrations were decreased considerably below those obtained with free insulin or with the same liposomes devoid of insulin, for up to at least 24h (Fig. 1) . Decrease in blood glucose 561st MEETING, LEEDS
